SV Perfusion (0736.634.331): financials and annual accounts

SV Perfusion

Profondeville ·KBO/BCE: BE 0736.634.331

Line	2025	2024	2023	2022	2021	2020
Balance sheet: assets
`20/58`	290,389	227,915	169,377	123,966	90,229	65,959
`21/28`	3,860	8,120	302	1,064	1,826	43
`22/27`	3,817	8,077	259	1,021	1,783	-
`24`	3,817	8,077	259	1,021	1,783	-
`28`	43	43	43	43	43	43
`29/58`	286,529	219,795	169,075	122,902	88,403	65,916
`40/41`	13,286	11,812	11,679	9,968	10,708	9,452
`40`	13,286	11,812	11,679	9,968	10,708	9,452
`50/53`	269,850	-	-	-	-	-
`54/58`	3,393	204,610	154,116	108,669	73,976	52,800
`490/1`	-	3,373	3,280	4,265	3,719	3,664
Balance sheet: equity and liabilities
`10/49`	290,389	227,915	169,377	123,966	90,229	65,959
`10/15`	234,491	213,295	154,486	104,195	74,518	47,713
`10/11`	3,000	3,000	3,000	3,000	3,000	3,000
`13`	223,500	203,500	145,000	95,000	66,000	40,000
`133`	223,500	203,500	145,000	95,000	66,000	40,000
`14`	7,991	6,795	6,486	6,195	5,518	4,713
`17/49`	55,898	14,620	14,891	19,771	15,711	18,246
`42/48`	53,218	11,931	12,202	17,183	13,129	18,246
`44`	726	869	843	989	1,058	813
`440/4`	726	869	843	989	1,058	813
`45`	11,958	7,408	7,486	12,407	11,221	17,208
`450/3`	11,958	7,408	7,486	12,407	11,221	17,208
`47/48`	40,534	3,654	3,873	3,787	850	225
`492/3`	2,680	2,689	2,689	2,588	2,582	-
Income statement
`70`	156,782	158,043	149,519	121,564	127,606	156,663
`9900`	90,437	84,446	73,223	44,649	41,298	61,924
`60/61`	70,599	77,935	80,846	81,405	86,308	94,919
`630`	4,260	701	762	762	526	-
`640/8`	928	899	870	794	1,306	-
`66A`	-	200	85	62	-	-
`9901`	85,249	82,646	71,506	43,031	39,466	61,924
`65/66B`	96	429	729	955	1,176	3
`65`	96	429	729	955	1,176	3
`9903`	85,153	82,217	70,777	42,076	38,290	61,921
`67/77`	23,957	23,408	20,486	12,399	11,485	17,208
`9904`	61,196	58,809	50,291	29,677	26,805	44,713
`9905`	61,196	58,809	50,291	29,677	26,805	44,713
Appropriation of the result
`9906`	67,991	65,295	56,486	35,195	31,518	44,713
`14P`	6,795	6,486	6,195	5,518	4,713	-
`791/2`	40,000	-	-	-	-	-
`691/2`	60,000	58,500	50,000	29,000	26,000	40,000
`6921`	60,000	58,500	50,000	29,000	26,000	40,000
`694/7`	40,000	-	-	-	-	-
`694`	40,000	-	-	-	-	-
Document	PDF	PDF	PDF	PDF	PDF	PDF

Financial year	Type	Filed	Reference	Document
31-12-2025	micro format	10-08-2026	2026-00389586	PDF
31-12-2024	micro format	19-08-2025	2025-00387768	PDF
31-12-2023	micro format	28-08-2024	2024-00380987	PDF
31-12-2022	micro format	29-08-2023	2023-00376880	PDF
31-12-2021	micro format	23-08-2022	2022-20305717	PDF
31-12-2020	micro format	30-08-2021	2021-57700104	PDF

2025	2024	2023	2022	2021	2020
89,509	83,347	72,268	43,793	39,992	-
65,456	59,510	51,053	30,439	27,331	-
0	8,519	0	0	2,309	43
-201,217	50,494	45,447	34,693	21,176	-
233,311	207,864	156,873	105,719	75,274	47,670
54.4%	52.3%	47.8%	35.4%	30.9%	39.5%
80.8%	93.6%	91.2%	84.1%	82.6%	72.3%
5.38	18.42	13.86	7.15	6.73	3.61
0.24	0.07	0.10	0.19	0.21	0.38
26.1%	27.6%	32.6%	28.5%	36.0%	93.7%
21.1%	25.8%	29.7%	23.9%	29.7%	67.8%
over 100	over 100	99.13	45.86	34.01	-
31 days	27 days	29 days	30 days	31 days	22 days
4 days	4 days	4 days	4 days	4 days	3 days

Item	2025	2024	2023	2022	2021
Tangible fixed assets	-	€8,519	-	-	€2,309
	€4,260	€701	€762	€762	€526

SV Perfusion

Annual accounts 2025

Money flows

Balance sheet

in euro

in euro

Filed annual accounts

Filings

Key figures and ratios

Investments

Insights on SV Perfusion

Next steps

Annual accounts 2025

Money flows

Balance sheet

Change in equityin euro

Change in cashin euro

Filed annual accounts

Filings

Key figures and ratios

Investments

Insights on SV Perfusion

Next steps

in euro

in euro